Surgical treatment of renal hyperparathyroidism

被引:4
作者
Tominaga, Y
Numano, M
Tanaka, Y
Uchida, K
Takagi, H
机构
[1] Department of Transplant Surgery, Nagoya Second Red Cross Hospital, Nagoya
[2] Department of Surgery II, Nagoya University, School of Medicine, Nagoya
[3] Department of Transplant Surgery, Kakegawa General Hospital, Kakegawa
[4] Department of Transplant Surgery, Nagoya Second Red Cross Hospital, Showa-ku, Nagoya 466
来源
SEMINARS IN SURGICAL ONCOLOGY | 1997年 / 13卷 / 02期
关键词
secondary hyperparathyroidism chronic renal failure; parathyroidectomy; persistent/recurrent hyperparathyroidism;
D O I
10.1002/(SICI)1098-2388(199703/04)13:2<87::AID-SSU4>3.0.CO;2-Y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Advanced secondary (renal) hyperparathyroidism induced by chronic renal disturbance is one of the most serious complications for long-term hemodialysis patients. Parathyroidectomy is indicated in patients with severely advanced renal hyperparathyroidism refractory to medical treatment (including calcitriol pulse therapy) and the clinical effect of parathyroidectomy is striking. However, skeletal deformity, vessel calcification, and remarkable reduction of bone content is irreversible, and it is important to perform parathyroidectomy at right time. Based on histopathological and pathophysiological investigations, nodular hyperplasia is monoclonal neoplasia with abnormal parathyroid hormone (PTH) response to extracellular calcium and vitamin D. When parathyroid hyperplasia progresses to nodular hyperplasia, parathyroidectomy should be required. Total parathyroidectomy with forearm autograft is the preferable procedure for renal hyperparathyroidism, especially for patients who need to continue hemodialysis treatment after parathyroidectomy. Removal of all parathyroid glands, including supernumerary glands, at the initial operation, and proper choice of adequate parathyroid tissue for autograft, are important to prevent persistent and recurrent hyperparathyroidism. Preoperative image diagnosis is useful for localization, and routine resection of thymic tissue is necessary to remove supernumerary glands. In our series of 548 patients, graft-dependent recurrent hyperparathyroidism was not negligible and the incidence was about 20% at the 5th year postoperatively. Enlarged autografts of parathyroid tissue could be removed from forearm under local anesthesia with fewer invasions. The function of autografted parathyroid tissue is nearly satisfactory and no re-transplantation of cryopreserved parathyroid tissue was necessary. To avoid adynamic bone disease, relatively high PTH level is required-over-suppression of PTH by excess of vitamin D and calcium salts should be avoided. In our experience, total parathyroidectomy with forearm autograft is very effective and adequate treatment for advanced renal hyperparathyroidism, and parathyroid function can be controlled after parathyroidectomy. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 41 条
[1]  
AKERSTROM G, 1984, SURGERY, V95, P14
[2]  
Akizawa T, 1993, Curr Opin Nephrol Hypertens, V2, P558, DOI 10.1097/00041552-199307000-00006
[3]   INTRAVENOUS CALCITRIOL IN THE TREATMENT OF REFRACTORY OSTEITIS FIBROSA OF CHRONIC RENAL-FAILURE [J].
ANDRESS, DL ;
NORRIS, KC ;
COBURN, JW ;
SLATOPOLSKY, EA ;
SHERRARD, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :274-279
[4]   MONOCLONALITY OF PARATHYROID TUMORS IN CHRONIC-RENAL-FAILURE AND IN PRIMARY PARATHYROID HYPERPLASIA [J].
ARNOLD, A ;
BROWN, MF ;
URENA, P ;
GAZ, RD ;
SARFATI, E ;
DRUEKE, TB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2047-2053
[5]   RECURRENCE OF HYPERPARATHYROIDISM AFTER TOTAL PARATHYROIDECTOMY WITH AUTOTRANSPLANTATION - A NEW TECHNIQUE TO LOCALIZE THE SOURCE OF HORMONE EXCESS [J].
DEFRANCISCO, ALM ;
AMADO, JA ;
CASANOVA, D ;
BRIZ, E ;
RIANCHO, J ;
COTORRUELO, J ;
DEBONIS, E ;
CANGA, E ;
ARIAS, M .
NEPHRON, 1991, 58 (03) :306-309
[6]   PARATHYROID-HORMONE SUPPRESSION BY INTRAVENOUS 1,25-DIHYDROXYVITAMIN-D - A ROLE FOR INCREASED SENSITIVITY TO CALCIUM [J].
DELMEZ, JA ;
TINDIRA, C ;
GROOMS, P ;
DUSSO, A ;
WINDUS, DW ;
SLATOPOLSKY, E .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1349-1355
[7]   1-ALPHA-HYDROXYVITAMIN-D-3 DERIVATIVES IN THE TREATMENT OF RENAL BONE-DISEASES - JUSTIFICATION AND OPTIMAL MODALITIES OF ADMINISTRATION [J].
FOURNIER, A ;
MORINIERE, P ;
OPRISIU, R ;
YVERNEAUHARDY, P ;
WESTEEL, PF ;
MAZOUZ, H ;
ELESPER, N ;
GHAZALI, A ;
BOUDAILLIEZ, B .
NEPHRON, 1995, 71 (03) :254-283
[8]   SERIAL EVALUATION OF PARATHYROID SIZE BY ULTRASONOGRAPHY IS ANOTHER USEFUL MARKER FOR THE LONG-TERM PROGNOSIS OF CALCITRIOL PULSE THERAPY IN CHRONIC DIALYSIS PATIENTS [J].
FUKAGAWA, M ;
KITAOKA, M ;
YI, H ;
FUKUDA, N ;
MATSUMOTO, T ;
OGATA, E ;
KUROKAWA, K .
NEPHRON, 1994, 68 (02) :221-228
[9]  
FUKAGAWA M, 1990, NEW ENGL J MED, V323, P421
[10]   DECREASED 1,25-DIHYDROXYVITAMIN-D(3) RECEPTOR DENSITY IS ASSOCIATED WITH A MORE SEVERE FORM OF PARATHYROID HYPERPLASIA IN CHRONIC UREMIC PATIENTS [J].
FUKUDA, N ;
TANAKA, H ;
TOMINAGA, Y ;
FUKAGAWA, M ;
KUROKAWA, K ;
SEINO, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1436-1443